Plasma Exosomal miR-450b-5p as a Possible Biomarker and Therapeutic Target for Transient Ischaemic Attacks in Rats
- 102 Downloads
Transient ischaemic attack (TIA) and cerebral infarction are difficult to identify within the thrombolytic time window. Blood markers are efficient, economical and noninvasive and can be beneficial in the diagnosis of many diseases. Plasma exosomal biomarkers are rarely reported in TIA. Exosomal microRNAs (miRNAs) were extracted from plasma and cerebrospinal fluid after middle cerebral artery occlusion (MCAo) in rats (0 min, 5 min, 10 min, 2 h). Deep sequencing was used to detect exosomal miRNAs in rat plasma and confirm significant differentially expressed miRNAs. Polymerase chain reaction (PCR) was used to detect the differentially expressed miRNAs in plasma and cerebrospinal fluid. Exosomal miRNAs with the same expression trends in plasma and cerebrospinal fluid were selected, and bioinformatics analysis was then carried out. Finally, the area under the curve (AUC) of the receiver operating characteristic (ROC) curve was determined to assess the diagnostic accuracy of miRNAs for TIA in rats. First, high-throughput sequencing was used to detect the expression level of plasma exosome miRNA, and rno-miR-450b-5p with a decreasing expression level was screened. Second, the expression levels of exosomal miRNAs were verified in cerebrospinal fluid and plasma samples by PCR, and the results indicated that exosomal rno-miR-450b-5p was similarly expressed in cerebrospinal fluid and plasma. ROC analysis showed high AUC values for rno-miR-450b-5p (0.880) in the 10 min ischaemia rats compared with the control rats. Finally, bioinformatic analysis indicated that exosomal rno-miR-450b-5p may be involved in cerebral ischaemia. Plasma exosomal rno-miR-450b-5p has a high diagnostic value and may become a therapeutic target for rat TIA.
KeywordsTransient ischaemic attack Plasma/cerebrospinal fluid exosomes Droplet digital PCR Biomarker Rno-miR-450b-5p
This study was supported by a grant from the National Natural Science Foundation of China (No. 81660354).
Compliance with Ethical Standards
Animals were treated in accordance with animal ethics standards throughout the animal experiment.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Consent for Publication
All authors agree to publish.
- Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205. https://doi.org/10.1146/annurev.cellbio.23.090506.123406 CrossRefPubMedGoogle Scholar
- Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S (2007) Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 369:293–298. https://doi.org/10.1016/s0140-6736(07)60151-2 CrossRefPubMedPubMedCentralGoogle Scholar
- Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, Cheng HH, Arroyo JD, Meredith EK, Gallichotte EN, Pogosova-Agadjanyan EL, Morrissey C, Stirewalt DL, Hladik F, Yu EY, Higao CS, Tewari M (2014) Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A 111(41):14888–14893. https://doi.org/10.1073/pnas.1408301111 CrossRefPubMedPubMedCentralGoogle Scholar
- Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC (2009a) Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 40(6):2276–2293. https://doi.org/10.1161/STROKEAHA.108.192218 CrossRefPubMedGoogle Scholar
- Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL, American Heart Association, American Stroke Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, Interdisciplinary Council on Peripheral Vascular Disease (2009b) Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40:2276–2293. https://doi.org/10.1161/STROKEAHA.108.192218 CrossRefPubMedGoogle Scholar
- Fan Y, Zhang C, Li T, Peng W, Yin J, Li X, Kong Y, Lan C, Wang R, Hu Z (2016) A new approach of short wave protection against middle cerebral artery occlusion/reperfusion injury via attenuation of Golgi apparatus stress by inhibition of downregulation of secretory pathway Ca(2+)-ATPase isoform 1 in rats. J Stroke Cerebrovasc Dis 25(7):1813–1822 doi: 10.1016/jCrossRefGoogle Scholar
- Li M et al (2018) All-trans retinoic acid ameliorates the early experimental cerebral ischemia-reperfusion injury in rats by inhibiting the loss of the blood-brain barrier via the JNK/P38MAPK signaling pathway. Neurochem Res 43:1283–1296. https://doi.org/10.1007/s11064-018-2545-4 CrossRefPubMedGoogle Scholar
- Shono K, Satomi J, Tada Y, Kanematsu Y, Yamamoto N, Izumi Y, Kaji R, Harada M, Nagahiro S (2017) Optimal timing of diffusion-weighted imaging to avoid false-negative findings in patients with transient ischemic attack. Stroke 48:1990–1992. https://doi.org/10.1161/STROKEAHA.117.014576 CrossRefPubMedGoogle Scholar
- Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kimura R, Mine S, Kamitsukasa I, Wada T, Aotsuka A, Yoshida Y, Kobayashi E, Matsutani T, Iwadate Y, Sugimoto K, Mori M, Uzawa A, Muto M, Kuwabara S, Takemoto M, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Machida T, Takizawa H, Kashiwado K, Shimada H, Ito M, Goto KI, Iwase K, Ashino H, Taira A, Arita E, Takiguchi M, Hiwasa T (2017) Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget. 9(5):5600–5613. https://doi.org/10.18632/oncotarget.23789 eCollection 2018 Jan 19CrossRefPubMedPubMedCentralGoogle Scholar
- Ye YP, Wu P, Gu CC, Deng DL, Jiao HL, Li TT, Wang SY, Wang YX, Xiao ZY, Wei WT, Chen YR, Qiu JF, Yang RW, Lin J, Liang L, Liao WT, Ding YQ (2016) miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Oncotarget. 7(38):61312–61324. https://doi.org/10.18632/oncotarget.11016 CrossRefPubMedPubMedCentralGoogle Scholar